Home » Topics » BioWorld Science

BioWorld Science
RSS

SKB reveals selective inhibitors of bacterial enzyme

Dec. 5, 1997

DuPont Merck develops novel CRF antagonists

Dec. 5, 1997

New tacrine analogue designated for further development

Dec. 5, 1997

Oncaspar approved in Canada

Dec. 5, 1997

VIMRx: Q3 1997 highlights

Dec. 5, 1997

Sugen initiates phase II prostate cancer trial with SU-101

Dec. 5, 1997

Preclinical results reported for JTE-522, a selective COX-2 inhibitor

Dec. 5, 1997

Genta to evaluate G-3139 in U.S. prostate cancer trial

Dec. 5, 1997

FR-173657 effective in models of kinin-dependent inflammation

Dec. 5, 1997

FDA clears IND for ImmuLogic's cocaine vaccine

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...